• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Multiple Sclerosis Treatments Associated with Reduced Uveitis Relapses in Retrospective Study

by
November 19, 2026
in Health
Reading Time: 2 mins read
0
Multiple Sclerosis Treatments Associated with Reduced Uveitis Relapses in Retrospective Study

Multiple Sclerosis Treatments Associated with Reduced Uveitis Relapses in Retrospective Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a retrospective study tracking patients diagnosed with both multiple sclerosis and uveitis, ocular inflammation flare-ups occurred largely independently of neurological relapses. Researchers evaluating 49 adult patients found that episodes of uveitis and neurological attacks were temporally dissociated in 94.2 percent of documented cases, highlighting a distinct clinical pattern between central nervous system events and intraocular inflammatory activity.

The temporal relationship between uveitis and neurological relapses in multiple sclerosis–associated uveitis is poorly documented. Furthermore, clinicians have sought clearer evidence regarding whether systemic disease-modifying therapies targeted at multiple sclerosis exert a measurable influence on the long-term course and recurrence of inflammatory eye disease.

To investigate these questions, investigators conducted a retrospective multicenter study drawing patient records from the Lyon Uvéite cohort, the European Database for Multiple Sclerosis, and broader open calls for case reporting. Eligible individuals were at least 18 years of age, held a confirmed multiple sclerosis diagnosis meeting McDonald criteria, and had their uveitis independently validated by an ophthalmologist.

The study protocol defined concomitant disease activity as uveitis and neurological flares taking place within a three-month window. Across the cohort, the 49 included patients were followed for a median duration of 19 years, with an interquartile range spanning 10 to 25 years, providing extensive longitudinal documentation of disease trajectories and therapeutic interventions over time.

To evaluate treatment effectiveness, the authors analyzed the probability of uveitis recurrence by comparing multiple sclerosis-targeted disease-modifying therapies directly against standard uveitis-directed treatments. Recurrent-event analyses accounting for time-varying treatment exposure revealed that patients receiving multiple sclerosis-targeted therapies experienced a significantly lower risk of uveitis relapse, yielding an adjusted hazard ratio of 0.20 with a 95 percent confidence interval of 0.08 to 0.54 and a p-value of 0.002.

The authors concluded that uveitis in individuals with multiple sclerosis operates largely dissociated from active neurological relapses, while systemic disease-modifying therapies directed at multiple sclerosis are associated with reduced uveitis recurrences. However, the authors noted that these exploratory findings require confirmation in prospective studies.

Subject of Research: Clinical course of multiple sclerosis-associated uveitis and treatment outcomes

Article Title: Clinical course of multiple sclerosis-associated uveitis: a retrospective series of 49 cases

Article References: Gil, W., Mainbourg, S., Jacquot, R., Trefond, L., Olagne, L., Clavelou, P., Trouillier, S., Bardy, A., Andre, M., Androdias-Condemine, G., Vasseneix, C., Kodjikian, L., El-Jammal, T., Vukusic, S., & Sève, P. (2026). Clinical course of multiple sclerosis-associated uveitis: a retrospective series of 49 cases. Journal of Ophthalmic Inflammation and Infection. https://doi.org/10.1186/s12348-026-00624-8

Image Credits: AI Generated

DOI: 10.1186/s12348-026-00624-8

Keywords: multiple sclerosis, uveitis, neuro-ophthalmology, disease-modifying therapies, ocular inflammation, neurological relapses, ophthalmology, retrospective study, McDonald criteria, Kaplan-Meier analysis, EDMUS, Lyon Uvéite cohort, autoimmune disease, clinical neurology, ocular flare, recurrent-event analysis

News Source: Ophelia Keating. (November 19, 2026). Multiple Sclerosis Treatments Associated with Reduced Uveitis Relapses in Retrospective Study. Scienmag.

Tags: autoimmune diseaseclinical neurologyDisease-modifying therapiesEDMUSKaplan-Meier analysisLyon Uvéite cohortMcDonald criteriaMultiple Sclerosisneuro-ophthalmologyneurological relapsesocular flareocular inflammationOphthalmologyrecurrent-event analysisRetrospective studyuveitis
Share12Tweet7Share2ShareShareShare1

Related Posts

Vacuum Assisted Closure Shows Similar Wound Dehiscence Rates Following Pediatric Anorectoplasty

Vacuum Assisted Closure Shows Similar Wound Dehiscence Rates Following Pediatric Anorectoplasty

November 19, 2026
Biodegradable Polylactic Acid Microplastics Induce Hepatic Ferroptosis and Fatty Liver in Carp

Biodegradable Polylactic Acid Microplastics Induce Hepatic Ferroptosis and Fatty Liver in Carp

November 19, 2026

Review Outlines Extraction and Health Benefits of Blackcurrant Polysaccharides

November 19, 2026

Canadian Focus Groups Reveal Core Lessons for Wildlife One Health Integration

November 19, 2026

POPULAR NEWS

  • Review Outlines Extraction and Health Benefits of Blackcurrant Polysaccharides

    Review Outlines Extraction and Health Benefits of Blackcurrant Polysaccharides

    29 shares
    Share 12 Tweet 7
  • Canadian Focus Groups Reveal Core Lessons for Wildlife One Health Integration

    29 shares
    Share 12 Tweet 7
  • Bevacizumab Biosimilar Shows Similar Blood Clot Risk to Reference Drug in Cancer Study

    29 shares
    Share 12 Tweet 7
  • Biotelemetry Array Identifies Wild Murray Cod Nesting Sites in Turbid Waters

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Vacuum Assisted Closure Shows Similar Wound Dehiscence Rates Following Pediatric Anorectoplasty

Biodegradable Polylactic Acid Microplastics Induce Hepatic Ferroptosis and Fatty Liver in Carp

Review Outlines Extraction and Health Benefits of Blackcurrant Polysaccharides

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 90 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.